VEGF 165 Gene Therapy for Patients with Refractory Angina: Mobilization of Endothelial Progenitor Cells

Abstract

BackgroundVascular endothelial growth factor (VEGF) induces mobilization of endothelial progenitor cells (EPCs) with the capacity for proliferation and differentiation into mature endothelial cells, thus contributing to the angiogenic process. ObjectiveWe sought to assess the behavior of EPCs in patients with ischemic heart disease and refractory angina who received an intramyocardial injections of 2000 µg of VEGF 165 as the sole therapy. MethodsThe study was a subanalysis of a clinical trial. Patients with advanced ischemic heart disease and refractory angina were assessed for eligibility. Inclusion criteria were as follows: signs and symptoms of angina and/or heart failure despite maximum medical treatment and a myocardial ischemic area of at least 5% as assessed by single-photon emission computed tomography (SPECT). Exclusion criteria were as follows: age > 65 years, left ventricular ejection fraction < 25%, and a diagnosis of cancer. Patients whose EPC levels were assessed were included. The intervention was 2000 µg of VEGF 165 plasmid injected into the ischemic myocardium. The frequency of CD34+/KDR+ cells was analyzed by flow cytometry before and 3, 9, and 27 days after the intervention. ResultsA total of 9 patients were included, 8 males, mean age 59.4 years, mean left ventricular ejection fraction of 59.3% and predominant class III angina. The number of EPCs on day 3 was significantly higher than that at baseline (p = 0.03); however, that on days 9th and 27th was comparable to that at baseline. ConclusionWe identified a transient mobilization of EPCs, which peaked on the 3th day after VEGF 165 gene therapy in patients with refractory angina and returned to near baseline levels on 9th and 27thdays.

Effects of different mesenchymal stromal cell sources and delivery routes in experimental emphysema

“…We observed that IV administration of BM-MSC and AD-MSC increased VEGF levels in lung tissue, which was not observed with the IT route. Based on previous studies of cardiac revascularization [ 50 , 51 ], we hypothesize that the systemic injection of BM-MSCs and AD-MSCs results in direct contact with the remaining endothelial cells of the pulmonary vasculature, stimulating them to synthesize VEGF. Intense neutrophilia in the sputum of COPD patients correlates positively with disease severity and high production of IL-8 [ 52 ].…”

Ginkgolide B promotes cell growth in endothelial progenitor cells through miR-126 and the Akt signaling pathway

“…Angiogenesis is a highly-regulated process that is important in tissue repair, regeneration and embryonic development, with EPCs serving a central role in these functions (13). Previous studies have demonstrated that EPCs exhibit characteristics of directional differentiation into endothelial cells by homing in an ischemic region (14). EPCs not only participate in angiogenesis during embryonic development, but can also be differentiated into endothelial cells following birth (15).…”

Synergistic effect of VEGF and SDF-1α in endothelial progenitor cells and vascular smooth muscle cells

“…It has been reported that EPCs are the most advantageous source of seed cells for vascular repair due to their ability maintain vascular endothelial function and integrity (Landmesser et al, 2004). EPCs are recruited by cytokines and inflammatory factors to the intimal lining of the injured region and stimulate migration and proliferation of the neighboring endothelial cells by secreting angiogenic growth factors (Rodrigues et al, 2013). EPCs play a key role in the treatment of vascular stenosis; however, endogenous EPCs are limited in number and are insufficient to meet the need of clinical applications.…”